AP Healthcare Inc. (KOSDAQ:109960)

Market Cap	97.57B
Revenue (ttm)	16.03B
Net Income (ttm)	16.12B
Shares Out	200.75M
EPS (ttm)	128.81
PE Ratio	3.77
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,573,567
Average Volume	602,305
Open	486.00
Previous Close	485.00
Day's Range	486.00 - 519.00
52-Week Range	402.00 - 808.00
Beta	0.66
RSI	53.28
Earnings Date	Mar 14, 2025

About AP Healthcare

AP Healthcare Inc. distributes pharmaceutical products in South Korea. It offers prescription and over-the-counter medication, such as antibiotics, antifungal agent, antiviral drugs, infusion solution, peptic ulcer medication, osteoarthritis treatment, purifying solvent, brain function improvement agent, respiratory solvent, topical medicine, adrenocorticosteroids, urinary medicine, hair loss treatment, antipyretic analgesic and anti-inflammatory agent, antihistamines, obesity agents, neural contract, liver extract, fire extinguisher solvent, e...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1998
• Employees: 15
• Stock Exchange: KOSDAQ
• Ticker Symbol: 109960

Financial Performance

In 2023, AP Healthcare's revenue was 16.01 billion, an increase of 66.77% compared to the previous year's 9.60 billion. Earnings were 4.30 billion, an increase of 77.09%.